Assignee
CODE BIOTHERAPEUTICS INC
US·4 granted patents·5 pending applications·2 citations·filing 2017–2024
Top patents by PatentIndex Score
9 records- 0183US11802151B2Brain-specific angiogenesis inhibitor 1 (BAI1) antibodies and uses thereofCODE BIOTHERAPEUTICS INC·Filed 2020·Granted Oct 31, 2023·2 cites·18 claims
- 0271US2025049942A1Nucleic acid carriers and therapeutic methods of useCODE BIOTHERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 0364US12195531B2Cellular delivery of DNA intercalating agentsCODE BIOTHERAPEUTICS INC·Filed 2019·Granted Jan 14, 2025·0 cites·17 claims
- 0463US2023136794A1Nucleic Acid Carriers And Therapeutic Methods Of UseCODE BIOTHERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 0561US2023338557A1Enhanced dna dendrimers and methods of use thereofCODE BIOTHERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 0658US2022143197A1siRNA Inhibition Of Human Antigen R Expression For Treatment of CancerCODE BIOTHERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 0757US12338435B2Nucleic acid carriers and therapeutic methods of useCODE BIOTHERAPEUTICS INC·Filed 2017·Granted Jun 24, 2025·0 cites·7 claims
- 0855US2024307548A1Enhanced targeting using antibody-oligonucleotide conjugatesCODE BIOTHERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 0953US12076410B2Nucleic acid carriers and therapeutic methods of useCODE BIOTHERAPEUTICS INC·Filed 2017·Granted Sep 3, 2024·0 cites·21 claims
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →